DK1335711T3 - Transdermal indretning - Google Patents

Transdermal indretning

Info

Publication number
DK1335711T3
DK1335711T3 DK01968531T DK01968531T DK1335711T3 DK 1335711 T3 DK1335711 T3 DK 1335711T3 DK 01968531 T DK01968531 T DK 01968531T DK 01968531 T DK01968531 T DK 01968531T DK 1335711 T3 DK1335711 T3 DK 1335711T3
Authority
DK
Denmark
Prior art keywords
agent
sampling
inhibiting
healing
delivery
Prior art date
Application number
DK01968531T
Other languages
English (en)
Inventor
Weiqi Lin
Michel J N Cormier
Peter E Daddona
Juanita A Johnson
James A Matriano
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK1335711T3 publication Critical patent/DK1335711T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DK01968531T 2000-09-08 2001-09-06 Transdermal indretning DK1335711T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23116000P 2000-09-08 2000-09-08
PCT/US2001/027551 WO2002019985A2 (en) 2000-09-08 2001-09-06 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure

Publications (1)

Publication Number Publication Date
DK1335711T3 true DK1335711T3 (da) 2007-11-26

Family

ID=22867983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01968531T DK1335711T3 (da) 2000-09-08 2001-09-06 Transdermal indretning

Country Status (24)

Country Link
US (1) US7438926B2 (da)
EP (1) EP1335711B1 (da)
JP (2) JP5507030B2 (da)
KR (1) KR100764699B1 (da)
CN (1) CN100421653C (da)
AT (1) ATE367805T1 (da)
AU (2) AU8877401A (da)
BR (1) BR0113749A (da)
CA (1) CA2422200A1 (da)
CZ (1) CZ2003687A3 (da)
DE (1) DE60129585T2 (da)
DK (1) DK1335711T3 (da)
EE (1) EE200300095A (da)
ES (1) ES2290166T3 (da)
IL (1) IL154811A0 (da)
MA (1) MA25958A1 (da)
MX (1) MXPA03002122A (da)
NO (1) NO20031071L (da)
NZ (1) NZ524646A (da)
PL (1) PL365603A1 (da)
PT (1) PT1335711E (da)
RU (1) RU2272618C2 (da)
WO (1) WO2002019985A2 (da)
ZA (1) ZA200302700B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1335711B1 (en) * 2000-09-08 2007-07-25 Alza Corporation Transdermal device
EP1333880B1 (en) * 2000-10-26 2009-04-15 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
BRPI0412029A (pt) 2003-06-30 2006-09-05 Alza Corp formulações para microprojeções revestidas contendo contra-ìons não-voláteis
AU2004253571A1 (en) * 2003-07-02 2005-01-13 Alza Corporation Microprojection array immunization patch and method
JP2007503268A (ja) 2003-08-25 2007-02-22 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答修飾化合物の送達
US20050090009A1 (en) * 2003-10-23 2005-04-28 Cormier Michel J. Compositions of stabilized DNA for coating microprojctions
CN1897898A (zh) * 2003-10-24 2007-01-17 阿尔扎公司 用于增强透皮药物传递的预处理方法和系统
BRPI0416042A (pt) * 2003-11-13 2007-01-02 Alza Corp composição e aparelho para suprimento transdérmico
CA2562932A1 (en) 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine
US20050226922A1 (en) * 2004-04-13 2005-10-13 Mahmoud Ameri Apparatus and method for transdermal delivery of fentanyl-based agents
CA2562642A1 (en) * 2004-04-13 2005-11-03 Alza Corporation Apparatus and method for transdermal delivery of multiple vaccines
KR20070042573A (ko) * 2004-08-11 2007-04-23 알자 코포레이션 나트륨 이뇨 펩티드의 경피 전달 장치 및 그 방법
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
JP5015787B2 (ja) 2004-11-18 2012-08-29 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルアレイの接触コーティング法
EP1827564B1 (en) * 2004-11-18 2015-07-29 3M Innovative Properties Company Masking method for coating a microneedle array
CN101160117A (zh) * 2005-02-16 2008-04-09 阿尔扎公司 依泊汀-基药物的透皮释放装置和方法
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
US20060253079A1 (en) * 2005-04-25 2006-11-09 Mcdonough Justin Stratum corneum piercing device
US20080195035A1 (en) * 2005-06-24 2008-08-14 Frederickson Franklyn L Collapsible Patch and Method of Application
US20070078414A1 (en) * 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
WO2007061781A1 (en) * 2005-11-18 2007-05-31 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
EP2018835B1 (de) * 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
CN102470118B (zh) * 2009-07-24 2014-12-17 21世纪国际新技术株式会社 含有NSAIDs的外用剂及该外用剂的制造方法
EP2818159A1 (de) * 2013-06-25 2014-12-31 LTS LOHMANN Therapie-Systeme AG Vorrichtung mit transdermalem therapeutischem System, Positionier- und Penetrationshilfe
US9987361B1 (en) * 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
DE102017126501A1 (de) 2017-11-10 2019-05-16 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes
US20190231925A1 (en) * 2018-01-31 2019-08-01 Changchun Ja Biotech. Co., Ltd. Heparin sodium supported hydrogel sustained-release paster

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
IL109037A (en) * 1993-03-19 1999-01-26 Cellegy Pharma Inc Preparations for causing phase separation of lipid layers and preparation of the above preparations
US5458140A (en) 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
EP0796128B1 (de) * 1994-12-09 1999-03-10 Novartis AG Transdermales system
AU5869796A (en) 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
WO1996037155A1 (en) 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical device and method for enhancing delivery of compounds through the skin
DE19525607A1 (de) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
US7184826B2 (en) 1996-06-18 2007-02-27 Alza Corporation Device and method for enhancing transdermal flux of agents being delivered or sampled
ES2200187T3 (es) 1996-07-03 2004-03-01 Altea Therapeutics Corporation Microporacion mecanica multiple de la piel o de la mucosa.
CA2265906C (en) 1996-09-17 2003-11-11 Deka Products Limited Partnership System for delivery of drugs by transport
AU722574B2 (en) 1996-12-20 2000-08-10 Alza Corporation Device and method for enhancing transdermal agent flux
DE19654391A1 (de) 1996-12-27 1998-07-02 Basf Ag Katalysator zur selektiven Herstellung von Propylen aus Propan
DE69737836T2 (de) * 1996-12-31 2008-03-06 Altea Therapeutics Corp. Mikroporation von Gewebe zur Verabreichung von bioaktiven Substanzen
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
CN1206004C (zh) * 1997-12-11 2005-06-15 阿尔扎有限公司 增强透皮物剂流量的装置
PT1037686E (pt) * 1997-12-11 2005-10-31 Alza Corp Aparelho para potenciar o fluxo de agente transdermico
WO1999029364A1 (en) * 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
AU767122B2 (en) 1998-06-10 2003-10-30 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
AU771818B2 (en) * 1999-05-17 2004-04-01 Stephen T Flock Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
CA2376128C (en) * 1999-06-04 2009-01-06 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
AU782610B2 (en) * 1999-12-10 2005-08-11 Alza Corporation Skin treatment apparatus for sustained transdermal drug delivery
ATE310561T1 (de) * 1999-12-10 2005-12-15 Alza Corp Vorrichtung und verfahren zur verbesserung des mikronadel-haut-piercing
EP1335711B1 (en) * 2000-09-08 2007-07-25 Alza Corporation Transdermal device
EP1333880B1 (en) * 2000-10-26 2009-04-15 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
AU2003275301A1 (en) * 2002-09-30 2004-04-23 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors

Also Published As

Publication number Publication date
MXPA03002122A (es) 2004-09-10
ES2290166T3 (es) 2008-02-16
IL154811A0 (en) 2003-10-31
AU8877401A (en) 2002-03-22
MA25958A1 (fr) 2003-12-31
KR20030074595A (ko) 2003-09-19
CN1473037A (zh) 2004-02-04
NZ524646A (en) 2004-10-29
US20020102292A1 (en) 2002-08-01
AU2001288774B2 (en) 2006-06-29
JP2004508319A (ja) 2004-03-18
CN100421653C (zh) 2008-10-01
ATE367805T1 (de) 2007-08-15
DE60129585D1 (de) 2007-09-06
WO2002019985A2 (en) 2002-03-14
CZ2003687A3 (cs) 2004-01-14
PT1335711E (pt) 2007-09-05
JP5507030B2 (ja) 2014-05-28
PL365603A1 (en) 2005-01-10
EE200300095A (et) 2005-02-15
BR0113749A (pt) 2004-06-22
KR100764699B1 (ko) 2007-10-08
EP1335711A2 (en) 2003-08-20
DE60129585T2 (de) 2008-04-17
WO2002019985A3 (en) 2002-09-06
NO20031071D0 (no) 2003-03-07
JP2013256500A (ja) 2013-12-26
ZA200302700B (en) 2004-08-13
US7438926B2 (en) 2008-10-21
NO20031071L (no) 2003-05-06
RU2272618C2 (ru) 2006-03-27
CA2422200A1 (en) 2002-03-14
EP1335711B1 (en) 2007-07-25

Similar Documents

Publication Publication Date Title
ATE367805T1 (de) Transdermale vorrichtung
BR0312671A (pt) Dispositivo de microagulhas, método para utilizar um dispositivo de microagulhas, e, método para aplicar um dispositivo de microagulhas
TW200605929A (en) Method and apparatus for reducing the incidence of tobacco use
PL363079A1 (en) Transdermal patch for administering fentanyl
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
WO2004006906A3 (en) Methods for the treatment of neoplasms
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
DK0764020T3 (da) Transdermalt system til indgivelse af lægemiddel
EA200301200A1 (ru) Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2
EA200802146A1 (ru) Трансдермальные способы и системы доставки препаратов против мигрени
WO2002078639A3 (en) A method of treating proliferative diseases using eg5 inhibitors
AU2002241736A1 (en) Method for preventing or treating pain by administering an endothelin antagonist
DE60112248D1 (de) Allzweck -medikament und -wärmebehandlungssystem
DK1450773T3 (da) Transdermalt terapeutisk system med forbedret langvarig bærekomfort
WO2007143185A3 (en) Transdermal treatment of tendinopathy using glyceryl trinitrite
WO2005037347A3 (en) Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
DE60213116D1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
GEP201606538B (en) Preoperative treatment of post operative pain
WO2007103190A3 (en) Transdermal treatment of tendinop athy using no donor
WO2002017928A3 (de) Transdermales therapeutisches system zur abgabe von exemestan
ATE372126T1 (de) Spüllösung und verfahren zur schmerzlinderung und entzündungshemmung
AU2002228314A1 (en) Means for retaining transcutaneous catheters and needles in place
DK1328273T3 (da) Anordning og fremgangsmåder til transdermal indgivelse af felodipin
TW200614985A (en) Compositions for the treatment of inflammation and pain using a combination of an NSAID and LTB4 receptor antagonist